Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes.Now, a clinical trial suggests the medicines can ...

A new stem cell treatment could eliminate the need for insulin therapy in people with type 1 diabetes, a disease where the ...

GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes, study finds Jul 22, 2025 Psychedelics and cannabis offer treatment hope for people with eating disorders ...

GLP-1 agonists, including liraglutide, are typically used to control blood sugar levels in type 2 diabetes and to promote weight loss. These drugs mimic a hormone released after eating, helping to ...

Based on this study, which has got to be one of the most well-designed studies with a placebo control in type 1 diabetes, I don't think there were any adverse events that would stop it from being ...

Now used for type 2 diabetes, new study shows GLP-1 drugs helped people with type 1 keep blood glucose levels in a healthy range while also losing weight. Skip to Main Content.

Sana is Incorporating the Tested Immune Evasion Technology to Develop SC451, a HIP-modified, Stem Cell-Derived Therapy as a One-Time Treatment for Patients with Type 1 Diabetes, with a Goal of ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with type 1 diabetes. Skip to main content Open menu Close menu ...